VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
ASM International N.V. vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
ASM International N.V.
ASM · Euronext Amsterdam
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into ASM International N.V.'s moat claims, evidence, and risks.
View ASM analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 74 / 100 for ASM International N.V.).
- Segment focus: ASM International N.V. has 3 segments; Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Primary market structure: Quasi-Monopoly vs Oligopoly. Pricing power: n/a vs Moderate.
- Moat breadth: ASM International N.V. has 5 moat types across 3 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
ASM International N.V.
ALD equipment
Single-wafer atomic layer deposition (ALD) equipment for semiconductor manufacturing
Global
Semiconductor manufacturers (logic/foundry, memory)
Wafer fab equipment supplier
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
ASM International N.V. strengths
Novo Nordisk A/S strengths
Segment mix
ASM International N.V. segments
Full profile >ALD equipment
Quasi-Monopoly
Silicon epitaxy equipment
Oligopoly
Spares and services
Quasi-Monopoly
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.